Full-Time

Senior Product Manager

HCP Marketing

Posted on 6/4/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Biotechnology

Compensation Overview

$140k - $160kAnnually

+ Bonus + Equity

Senior

New York, NY, USA

Required Skills
Market Research
Sales
Marketing
Data Analysis
Requirements
  • BA or BS required; advanced degree preferred
  • Migraine experience strongly preferred
  • Minimum 4-5 years of experience in pharmaceutical/biotechnology marketing, with a minimum of 2-3 years of experience successfully executing HCP-focused campaigns
  • Ability to work on site Monday, Tuesday & Thursday
Responsibilities
  • Contribute to the development of the marketing plans for AXS-07 and champion the plan through engagement with internal and external partners
  • Lead portions of the development of the integrated brand plan, create programs and tactics to support the strategy, and execute the tactical marketing plans focused on HCP audiences
  • Identify appropriate measurements & ROI, and develop comprehensive reporting to evaluate effectiveness of tactical efforts
  • Effectively manage key agency partners
  • Lead reviews of promotional materials with Regulatory/Legal/Medical
  • Collaborate effectively with sales & marketing, market access, market research, medical affairs, commercial operations, data & analytics, finance, and other cross-functional partners
  • Identify strategic market opportunities and make recommendations to enhance brand penetration
  • Develop mid- to long-range plan for future indications
  • Manage timelines and budgets in accordance with brand plan

Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

12%

1 year growth

45%

2 year growth

277%